View More Recent Stories

Oct 24, 2022 09:00AM Biora Therapeutics Shares Five Posters Presented at American College of Gastroenterology Annual Scientific Meeting 2022
Oct 19, 2022 09:01AM Biodrain Medical (BIOR) to Present Preclinical Data on Oral Delivery of Biologics
Oct 19, 2022 09:00AM Biora Therapeutics Shares Preclinical Data on Oral Delivery of Biologics at the 2022 Parenteral Drug Association Universe of Pre-Filled Syringes and Injection Devices Conference 
Oct 19, 2022 09:00AM Biora Therapeutics Shares Preclinical Data on Oral Delivery of Biologics at the 2022 Parenteral Drug Association Universe of Pre-Filled Syringes and Injection Devices Conference 
Oct 10, 2022 09:00AM Biora Therapeutics to Participate in 12th Annual Partnership Opportunities in Drug Delivery Conference
Oct 10, 2022 09:00AM Biora Therapeutics to Participate in 12th Annual Partnership Opportunities in Drug Delivery Conference
Sep 13, 2022 09:01AM Biodrain Medical, Inc. (BIOR) Issued Key Patent for Oral Delivery of GLP-1 Receptor Agonists
Sep 13, 2022 09:00AM Biora Therapeutics Announces Issuance of Key Patent for Oral Delivery of GLP-1 Receptor Agonists
Sep 13, 2022 09:00AM Biora Therapeutics Announces Issuance of Key Patent for Oral Delivery of GLP-1 Receptor Agonists
Sep 7, 2022 09:00AM Biora Therapeutics Appoints Dr. Bruce Sands as Chair of its Clinical Advisory Board
Sep 7, 2022 09:00AM Biora Therapeutics Appoints Dr. Bruce Sands as Chair of its Clinical Advisory Board
Sep 6, 2022 06:30AM Biora Therapeutics to Participate in Upcoming H.C. Wainwright Investment Conference
Sep 6, 2022 06:30AM Biora Therapeutics to Participate in Upcoming H.C. Wainwright Investment Conference
Aug 15, 2022 04:05PM Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2022 Financial Results
Aug 15, 2022 04:05PM Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2022 Financial Results
Aug 10, 2022 09:04AM Biodrain Medical, Inc. (BIOR) Announces Successful Completion of Device Performance Study in Ulcerative Colitis Patients for its Targeted Therapeutics Platform
Aug 10, 2022 09:00AM Biora Therapeutics Announces Successful Completion of Device Performance Study in Ulcerative Colitis Patients for its Targeted Therapeutics Platform
Aug 10, 2022 09:00AM Biora Therapeutics Announces Successful Completion of Device Performance Study in Ulcerative Colitis Patients for its Targeted Therapeutics Platform
Aug 8, 2022 09:00AM Biora Therapeutics to Report Second Quarter 2022 Financial Results and Provide Corporate Update
Aug 8, 2022 09:00AM Biora Therapeutics to Report Second Quarter 2022 Financial Results and Provide Corporate Update
Aug 3, 2022 09:00AM Biora Therapeutics Announces Five Abstracts Accepted at American College of Gastroenterology Annual Scientific Meeting 2022
Aug 3, 2022 09:00AM Biora Therapeutics Announces Five Abstracts Accepted at American College of Gastroenterology Annual Scientific Meeting 2022
Jul 26, 2022 09:00AM Biora Therapeutics to Participate in Upcoming BTIG Investment Conference
Jul 26, 2022 09:00AM Biora Therapeutics to Participate in Upcoming BTIG Investment Conference
Jul 14, 2022 09:00AM Biora Therapeutics Shares Preclinical Data on Oral Delivery of Biologics at Controlled Release Society 2022
Jul 14, 2022 09:00AM Biora Therapeutics Shares Preclinical Data on Oral Delivery of Biologics at Controlled Release Society 2022
Jul 7, 2022 09:00AM Biora Therapeutics Announces Successful Completion of Second Device Performance Study in Human Subjects for its Targeted Therapeutics Platform
Jul 7, 2022 09:00AM Biora Therapeutics Announces Successful Completion of Second Device Performance Study in Human Subjects for its Targeted Therapeutics Platform
Jun 22, 2022 09:00AM Biora Therapeutics Announces Presentation at the 2022 Parenteral Drug Association Universe of Pre-Filled Syringes and Injection Devices Conference
Jun 22, 2022 09:00AM Biora Therapeutics Announces Presentation at the 2022 Parenteral Drug Association Universe of Pre-Filled Syringes and Injection Devices Conference
May 31, 2022 09:00AM Biora Therapeutics Shares Presentation of Patient Data Establishing Correlation Between Drug Levels in Colon and Patient Outcomes in Ulcerative Colitis
May 31, 2022 09:00AM Biora Therapeutics Shares Presentation of Patient Data Establishing Correlation Between Drug Levels in Colon and Patient Outcomes in Ulcerative Colitis
May 25, 2022 09:00AM Biora Therapeutics Shares Data Presented at Digestive Disease Week 2022
May 25, 2022 09:00AM Biora Therapeutics Shares Data Presented at Digestive Disease Week 2022
May 19, 2022 09:00AM Biora Therapeutics Announces New Patents for Targeted Therapeutics Platform
May 19, 2022 09:00AM Biora Therapeutics Announces New Patents for Targeted Therapeutics Platform
May 16, 2022 04:30PM Biora Therapeutics to Participate in Upcoming H.C. Wainwright Global Investment Conference
May 16, 2022 04:30PM Biora Therapeutics to Participate in Upcoming H.C. Wainwright Global Investment Conference
May 10, 2022 04:01PM Biora Therapeutics Provides Corporate Update and Reports First Quarter 2022 Financial Results
May 10, 2022 04:01PM Biora Therapeutics Provides Corporate Update and Reports First Quarter 2022 Financial Results
View More Recent Stories